Blozo, Raymund A.
HRN: 27-32-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/06/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/06/2025
10/13/2025
IVT
300mg
Q6
Cellulitis, Right Lower Extremity
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes